Transgender In Transition
Recruiting
Observational Study
Gender Incongruence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 750 (estimated)
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Prospective trial in gender dysphoric patients who undergo gender-affirming hormone therapy, aiming to investigate psychological, biological and behavioural consequences of hormonal therapy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* diagnosis of gender incongruence (ICD-11) or gender dysphoria (DSM-5)
* written informed consent following adequate oral and written Information
* before gender-affirming hormonal treatment
Exclusion Criteria:
* pregnancy or breast-feeding
Contacts